Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Gerosa

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cell Systems|May 3, 2016
Pseudo-transition Analysis Identifies the Key Regulators of Dynamic Metabolic Adaptations from Steady-State DataLuca Gerosa, Bart R B Haverkorn van Rijsewijk, Dimitris Christodoulou, et al.
European Heart Journal. Imaging Methods and Practice|March 5, 2025
The impact of bicuspid valve morphology on the selection of transcatheter aortic valve implantation devices: an <i>in silico</i> studyBenedetta Grossi, Giulia Luraghi, Sara Barati, et al.
Nature|June 29, 2022
Structural basis for SHOC2 modulation of RAS signallingNicholas P D Liau, Matthew C Johnson, Saeed Izadi, et al.
Nature Communications|November 14, 2022
Multiplexed and reproducible high content screening of live and fixed cells using Dye DropCaitlin E Mills, Kartik Subramanian, Marc Hafner, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Cancers|August 29, 2024
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in MelanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Cell Reports|March 15, 2023
Multi-range ERK responses shape the proliferative trajectory of single cells following oncogene inductionJia-Yun Chen, Clemens Hug, José Reyes, et al.
Cancer Research|July 3, 2025
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted TherapyAshley V DiMarco, Mirunalini Ravichandran, Jeff Lau, et al.
Nature Communications|February 18, 2025
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibitionSayantanee Paul, Thijs J Hagenbeek, Julien Tremblay, et al.
Cell Systems|October 28, 2020
Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma CellsLuca Gerosa, Christopher Chidley, Fabian Fröhlich, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cell Systems|May 3, 2016
Pseudo-transition Analysis Identifies the Key Regulators of Dynamic Metabolic Adaptations from Steady-State DataLuca Gerosa, Bart R B Haverkorn van Rijsewijk, Dimitris Christodoulou, et al.
European Heart Journal. Imaging Methods and Practice|March 5, 2025
The impact of bicuspid valve morphology on the selection of transcatheter aortic valve implantation devices: an <i>in silico</i> studyBenedetta Grossi, Giulia Luraghi, Sara Barati, et al.
Nature|June 29, 2022
Structural basis for SHOC2 modulation of RAS signallingNicholas P D Liau, Matthew C Johnson, Saeed Izadi, et al.
Nature Communications|November 14, 2022
Multiplexed and reproducible high content screening of live and fixed cells using Dye DropCaitlin E Mills, Kartik Subramanian, Marc Hafner, et al.
Biorxiv : the Preprint Server for Biology|August 16, 2024
Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Cancers|August 29, 2024
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in MelanomaAndrew Goetz, Frances Shanahan, Logan Brooks, et al.
Cell Reports|March 15, 2023
Multi-range ERK responses shape the proliferative trajectory of single cells following oncogene inductionJia-Yun Chen, Clemens Hug, José Reyes, et al.
Cancer Research|July 3, 2025
RIT1M90I Is a Driver of Lung Adenocarcinoma Tumorigenesis and Resistance to Targeted TherapyAshley V DiMarco, Mirunalini Ravichandran, Jeff Lau, et al.
Nature Communications|February 18, 2025
Cooperation between the Hippo and MAPK pathway activation drives acquired resistance to TEAD inhibitionSayantanee Paul, Thijs J Hagenbeek, Julien Tremblay, et al.
Cell Systems|October 28, 2020
Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma CellsLuca Gerosa, Christopher Chidley, Fabian Fröhlich, et al.
Pageof 3